HyoSookHanMD

PubMed

• Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose ...
  E Claire Dees, Samuel Suzuki, Sarah C Mutka, Brian F Sullivan, Igor Gorbatchevsky, Rachel M Layman, Hyo S Han, Hope S Rugo, Erica M Stringer-Reasor, Jennifer M Specht,...> ;The Lancet. Oncology. 2024 Apr 1
• Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trial.
  Diéras, V., Wildiers, H., Friedlander, M., Ayoub, J., Puhalla, S., Loirat, D., Ratajczak, C., Adamu, H., Girardi, V., Han, H., Arun, B.> ;European Journal of Cancer. 2024 Mar 1
• Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development.
  Gautam, N., Ramamoorthi, G., Champion, N., Han, H., Czerniecki, B.> ;Molecular Aspects of Medicine. 2024 Feb 1
• Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
  Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain...> ;JAMA Network Open. 2023 Dec 1
• 1 citations
  Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases.
  Vaseem M Khatri, Matthew N Mills, Daniel E Oliver, Hsiang-Hsuan Michael Yu, Michael A Vogelbaum, Peter A Forsyth, Hatem H Soliman, Hyo S Han, Kamran A Ahmed> ;Journal of Neuro-Oncology. 2023 Aug 1
• 2 citations
  Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between.
  Hyo Sook Han, Praveen Vikas, Ricardo L B Costa, Nusrat Jahan, Ammanuel Taye, Erica M Stringer-Reasor> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
• 2 citations
  A Gene Panel Associated With Abemaciclib Utility in-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.
  Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, ...> ;JCO Precision Oncology. 2023 May 1
• Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.
  Hatem Soliman, Deanna Hogue, Hyo Han, Blaise Mooney, Ricardo Costa, Marie C Lee, Bethany Niell, Angela Williams, Alec Chau, Shannon Falcon, Aixa Soyano, Avan Armaghani...> ;Nature Medicine. 2023 Dec 1
• 1 citations
  Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer.
  Harshan Ravi, Andres M Arias-Lorza, James R Costello, Hyo Sook Han, Daniel K Jeong, Stephan G Klinz, Jasgit C Sachdev, Ronald L Korn, Natarajan Raghunand> ;Radiology. Imaging Cancer. 2023 Mar 1
• 16 citations
  Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.
  Hatem Soliman, Deanna Hogue, Hyo Han, Blaise Mooney, Ricardo Costa, Marie C Lee, Bethany Niell, Angela Williams, Alec Chau, Shannon Falcon, Aixa Soyano, Avan Armaghani...> ;Nature Medicine. 2023 Feb 1
• 1 citations
  Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast c...
  Mark Jesus M Magbanua, Laura van 't Veer, Amy S Clark, A Jo Chien, Judy C Boughey, Hyo S Han, Anne Wallace, Heather Beckwith, Minetta C Liu, Christina Yau, E Paul Wile...> ;Breast Cancer Research and Treatment. 2023 Apr 1
• 6 citations
  Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
  Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S Albain, Er...> ;NPJ Breast Cancer. 2022 Dec 1
• 1 citations
  Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.
  Laura M Spring, Hyo Han, Minetta C Liu, Erika Hamilton, Hanna Irie, Cesar A Santa-Maria, James Reeves, Peng Pan, Ming Shan, Yongqiang Tang, Julie R Graham, Sebastien H...> ;Nature Cancer. 2022 Sep 1
• 10 citations
  Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.
  Laura M Spring, Hyo Han, Minetta C Liu, Erika Hamilton, Hanna Irie, Cesar A Santa-Maria, James Reeves, Peng Pan, Ming Shan, Yongqiang Tang, Julie R Graham, Sebastien H...> ;Nature Cancer. 2022 Aug 1
• 6 citations
  Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma.
  Ganesan Ramamoorthi, Krithika Kodumudi, Colin Snyder, Payal Grover, Hongtao Zhang, Mark I Greene, Amrita Basu, Corey Gallen, Doris Wiener, Ricardo L B Costa, Hyo S Han...> ;Journal for Immunotherapy of Cancer. 2022 Jun 1
• 7 citations
  Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
  Matthew N Mills, Whitney King, Aixa Soyano, Yolanda Pina, Brian J Czerniecki, Peter A Forsyth, Hatem Soliman, Hyo S Han, Kamran A Ahmed> ;Journal of Neuro-Oncology. 2022 Apr 1
• 13 citations
  Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.
  Antoinette R Tan, Gail S Wright, Anu R Thummala, Michael A Danso, Lazar Popovic, Timothy J Pluard, Hyo S Han, Željko Vojnović, Nikola Vasev, Ling Ma, Donald A Richards...> ;Clinical Cancer Research. 2022 Feb 15
• 14 citations
  Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of ...
  Hyo S. Han, Banu Arun, Bella Kaufman, Hans Wildiers, Michael Friedlander, J.P. Ayoub, Shannon Puhalla, Bruce A. Bach, Madan Gopal Kundu, N. Khandelwal, D. Feng, S. Bha...> ;Annals of Oncology. 2021 Nov 30
• 34 citations
  Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
  Elias, A., Amy S. Clark, Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, Laura J. van't Veer, Douglas Yee, Stacy L. Moulder, Anne M. Wallace, A. Jo Chien, Claudin...> ;Nature Communications. 2021 Nov 5
• 7 citations
  Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
  Kamran Ahmed, Young-Chul Kim, John A. Arrington, Sungjune Kim, Michelle DeJesus, Aixa E. Soyano, Avan Armaghani, Ricardo Costa, Hung T. Khong, Loretta Loftus, Marilin ...> ;Advances in Radiation Oncology. 2021 Nov 1
• 5 citations
  The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs
  Matthew N. Mills, Thrisha K Potluri, Yuki Kawahara, Matthew Fahey, Nicholas B Figura, Aixa E. Soyano, Iman R. Washington, Roberto J. Diaz, Daniel E. Oliver, Hsiang-Hsu...> ;Breast Cancer Research and Treatment. 2021 Oct 20
• 12 citations
  Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
  Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero-Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kath...> ;NPJ Breast Cancer. 2021 Oct 5
• 8 citations
  Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia
  James Sun, Xiaojun Zhong, Junjie Ma, Weihong Sun, Hyo S. Han, Hatem Soliman, Loretta Loftus, Ricardo Costa, Avan Armaghani, Aixa E. Soyano‐Muller, Brian J. Czerniecki,...> ;Cancer Medicine. 2021 Sep 30
• 37 citations
  Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...
  W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein, Lajos Pusztai, Rita Nanda, Barbara A. Parker, Brian Datnow, Gregor Krings, Shi Wei, Mi...> ;JAMA Oncology. 2021 Sep 16
• 9 citations
  Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer...
  Shannon Puhalla, Véronique Diéras, Banu Arun, Bella Kaufman, Hans Wildiers, Hyo S. Han, Jean-Pierre M. Ayoub, Vered Stearns, Yuan Yuan, Teresa Helsten, Bridget Riley-G...> ;Clinical Cancer Research. 2021 Sep 15
• Join now to see all

Lectures

• SGNLVA-002: Single-arm, open label phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresect... 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019